Jpmorgan Chase & CO Ionis Pharmaceuticals Inc Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 568,906 shares of IONS stock, worth $20.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

568,906

Previous 594,091 4.24%

Holding current value

$20.3 Million

Previous $28.3 Million 19.51%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$40.06 - $51.86 $1.01 Million - $1.31 Million	-25,185 Reduced 4.24%	568,906 $22.8 Million
Q2 2024 Aug 12, 2024	SELL	$36.45 - $47.7 $1.34 Million - $1.76 Million	-36,888 Reduced 5.85%	594,091 $28.3 Million
Q1 2024 May 10, 2024	SELL	$42.03 - $53.55 $13 Million - $16.6 Million	-310,053 Reduced 32.95%	630,979 $27.4 Million
Q4 2023 Feb 12, 2024	BUY	$43.39 - $51.63 $1.73 Million - $2.06 Million	39,975 Added 4.44%	941,032 $47.6 Million
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $6.42 Million - $7.85 Million	-166,666 Reduced 15.61%	901,057 $40.9 Million
Q2 2023 Aug 11, 2023	BUY	$34.73 - $43.33 $358,691 - $447,512	10,328 Added 0.98%	1,067,723 $43.8 Million
Q1 2023 May 18, 2023	BUY	$33.58 - $41.2 $2.67 Million - $3.27 Million	79,417 Added 8.12%	1,057,395 $37.8 Million
Q1 2023 May 11, 2023	BUY	$33.58 - $41.2 $257,491 - $315,921	7,668 Added 0.79%	977,978 $35 Million
Q4 2022 Feb 13, 2023	BUY	$37.12 - $46.52 $1.54 Million - $1.93 Million	41,558 Added 4.47%	970,310 $36.6 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $4.05 Million - $5.39 Million	-110,818 Reduced 10.66%	928,752 $41.1 Million
Q2 2022 Aug 11, 2022	SELL	$31.71 - $43.0 $4.5 Million - $6.11 Million	-141,987 Reduced 12.02%	1,039,570 $38.5 Million
Q1 2022 May 11, 2022	SELL	$29.88 - $37.04 $2.6 Million - $3.23 Million	-87,095 Reduced 6.87%	1,181,557 $43.8 Million
Q4 2021 Feb 10, 2022	SELL	$25.61 - $35.1 $29.4 Million - $40.3 Million	-1,147,661 Reduced 47.5%	1,268,652 $38.6 Million
Q3 2021 Nov 12, 2021	BUY	$33.54 - $40.55 $81 Million - $98 Million	2,416,313 New	2,416,313 $81 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.06B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Ionis Pharmaceuticals Inc Transaction History